[1]
Y. Xiao, “Alectinib and SALL4-Targeted Fatty Acid Oxidation: A Strategy to Combat Oxaliplatin Resistance in Gastric Cancer”, Turkish Journal of Gastroenterology, vol. 36, no. 12, pp. 813–821, Jun. 2025.